Comprehensive Telehealth Wellness Care Across Multiple States
Semaglutide is a prescription medication that may help eligible adults achieve meaningful weight loss when combined with healthy nutrition, regular physical activity, and ongoing medical supervision. At Restore Wellness Clinic, we provide personalized telehealth weight loss treatment plans tailored to your medical history, health goals, and lifestyle. Medication is prescribed when clinically appropriate after a comprehensive medical evaluation.
Avg. Body Weight Reduction
Patients Achieved ≥5% Weight Loss
STEP-1 Trial Duration
Simple Weekly Injection
Semaglutide is a once-weekly medication used to support chronic weight management in appropriate patients. It works by activating the GLP-1 receptor, helping regulate appetite, slow stomach emptying, improve blood sugar control, and promote sustainable weight loss when combined with healthy lifestyle changes.
Semaglutide is the active ingredient in Ozempic® and Wegovy®. During your consultation, your provider will determine whether semaglutide or another evidence-based treatment is appropriate for your individual needs. If prescribed, your medication will be sent electronically to a licensed pharmacy for fulfillment.
Helps regulate appetite, slows stomach emptying, and supports healthy blood sugar regulation.
Increases feelings of fullness, helping reduce calorie intake and support long-term weight management.
Supports healthy glucose metabolism and sustainable weight loss when combined with healthy lifestyle habits.
Semaglutide works by activating the GLP-1 receptor, helping regulate appetite, slow stomach emptying, and improve feelings of fullness. These effects can help eligible patients reduce calorie intake and achieve meaningful weight loss when combined with healthy nutrition, regular physical activity, and ongoing medical supervision.
Target
Clinical studies, including the landmark STEP trials, have shown that Semaglutide can help eligible adults achieve significant and sustained weight loss when combined with healthy nutrition, regular physical activity, and ongoing medical care. At Restore Wellness Clinic, we use evidence-based treatment plans tailored to each patient’s medical history, health goals, and lifestyle to help support long-term success.
Average body weight reduction with Semaglutide 2.4mg — STEP-1 Trial (68 weeks)
Of patients achieved at least 5% weight loss
Of patients achieved at least 10% weight loss
Major STEP Phase 3 trials most comprehensive weight loss evidence base
The STEP (Semaglutide Treatment Effect in People with obesity) program comprised four Phase 3 randomized controlled trials. STEP-1 enrolled 1,961 adults with obesity or overweight and at least one weight-related comorbidity. Participants received once-weekly Semaglutide 2.4mg alongside lifestyle intervention over 68 weeks. The results established Semaglutide as a landmark advancement in obesity pharmacotherapy — and remain the most cited weight loss clinical trial data in medical literature. Additional STEP trials evaluated Semaglutide in patients with type 2 diabetes, cardiovascular disease, and with/without intensive behavioral therapy. *Individual results vary. Results shown reflect published clinical trial averages with lifestyle intervention.
Semaglutide (Wegovy®) is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. Always consult a qualified provider before starting any medication.
From your first consultation to lasting results a clear, provider-guided 4-step process with support at every stage.
Meet with your nurse practitioner to review your medical history, weight loss goals, and determine whether semaglutide is right for you. Lab testing may be recommended if medically necessary.
Receive a customized treatment plan tailored to your health goals, medical history, and response to treatment. Your dosage will be adjusted as needed for safety and effectiveness.
If prescribed, your medication will be delivered to your home. We'll provide clear instructions, injection guidance, and ongoing support to help you get started confidently.
Regular follow-up visits allow us to monitor your progress, manage side effects, and adjust your treatment plan to support long-term success.
Learn how your treatment plan may progress over time. Every patient’s dosage is personalized based on their response, goals, and clinical evaluation.
Most patients begin with a low starting dose to help their body adjust. Your provider will monitor your response before making any changes.
Most patients begin noticing meaningful weight loss. Provider reviews response before next step.
Appetite suppression becomes consistent. Weight loss accelerates.
Your treatment plan is adjusted based on your individual response. Some patients continue to lose weight at a lower doses, while other may benefit from a dose increase.
Your provider will determine the most appropriate maintenance dose based on your progress, goals, and how well you tolerate treatment.
The slow titration schedule for Semaglutide is the most effective way to minimize side effects while allowing your body to build tolerance and appetite suppression progressively. We never rush this process.
Your provider will not escalate your dose until you’ve tolerated your current dose comfortably. If you’re achieving excellent results at a lower dose there’s no clinical reason to go higher. Our goal is your success, not a maximum prescription
Self-administered injection into the abdomen, thigh, or upper arm. Easy to learn and fits into any weekly routine.
Semaglutide must be refrigerated. Our team provides complete storage, handling, and administration instructions at your first appointment.
Have questions? Our team is here to support you throughout your treatment journey.
Is This Right For You?
Our medically supervised programs are designed for individuals looking for safe, effective, and personalized weight management solutions.
Semaglutide is prescribed for eligible adults with a BMI of 30 or higher seeking medically supervised weight management.
If you have high blood pressure, type 2 diabetes, sleep apnea, or high cholesterol alongside overweight, you may be an ideal candidate.
Semaglutide has the most extensive real-world safety data of any weight loss medication available — years of post-market surveillance across millions of patients worldwide.
Semaglutide was originally developed for blood sugar management — making it particularly beneficial for patients with metabolic conditions alongside weight goals.
Successful weight management requires a long-term approach. We’re here to provide personalized guidance, ongoing support, and treatment tailored to your goals.
Semaglutide may not be appropriate for everyone. During your consultation, we’ll carefully review your medical history to determine whether this treatment is safe and appropriate for you.
Take the first step toward achieving your weight loss goals. Schedule a consultation to find out if tirzepatide is the right treatment for you.
Semaglutide’s benefits extend far beyond the number on a scale, it creates meaningful improvements across your metabolic and overall health.
Average 14.9% body weight reduction over 68 weeks in landmark STEP trials. For a 200lb person, that’s nearly 30lbs on average with 69% of patients achieving 10% or greater reduction.
Semaglutide acts directly on hunger-regulating centers in the brain, reducing both appetite and food cravings. Patients frequently describe a fundamental shift in their relationship with food.
Originally developed for type 2 diabetes, Semaglutide is highly effective at improving insulin sensitivity and stabilizing blood sugar making it especially valuable for patients with metabolic conditions.
The SELECT trial demonstrated a 20% reduction in major cardiovascular events with Semaglutide even independent of weight loss. This makes it uniquely valuable for patients with cardiovascular risk factors.
As weight decreases, energy levels, joint health, sleep quality, and physical capacity all typically improve. Patients describe feeling more active, mobile, and capable in daily life.
Semaglutide has been prescribed to millions of patients globally since 2017. Its safety profile is more thoroughly understood than any other weight loss medication providing exceptional confidence for long-term use.
We are not a one-size-fits-all clinic. Every patient receives individualized care, evidence-based treatment, and personalized provider support from your initial consultation to long-term success.
| Factor | Semaglutide We Offer | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 only | Dual GIP + GLP-1 |
| Avg. Weight Loss | Up to 14.9% | Up to 22.5% |
| FDA Approval (Obesity) | 2021 — 3+ years data | 2023 |
| Long-Term Safety Data | Most extensive available | Growing rapidly |
| Cardiovascular Data | SELECT trial — 20% CV risk ↓ | Trials ongoing |
| Blood Sugar Control | Proven in diabetes (SUSTAIN) | Stronger effect |
| Dosing | Once weekly | Once weekly |
While Tirzepatide produces greater average weight loss, Semaglutide has distinct advantages that make it the preferred choice for many patients. It has been prescribed globally since 2017, giving it years of extensive real-world safety observation that no newer medication can match.
For patients with established cardiovascular disease or risk factors, Semaglutide’s SELECT trial data showing a 20% reduction in major cardiovascular events provides a level of confidence that is uniquely compelling. For patients with type 2 diabetes, Semaglutide’s deep history in that indication offers additional clinical backing.
Some patients also simply prefer a medication with the most thoroughly understood long-term profile. Both medications are excellent. Your provider will recommend the most appropriate option based on your individual health picture, goals, and preferences.
Semaglutide is well-tolerated by most patients. Thanks to its extended safety record, side effects are well-characterized and manageable with the right approach.
Usually mild and temporary, especially during dose increases. Eating smaller meals and staying hydrated often helps.
Expected and desired, patients eat less because the medication is working. This is not a side effect to be concerned about.
Diarrhea, constipation, bloating, or stomach discomfort may occur in early weeks. These effects are well-documented in clinical literature and typically transient
Mild redness or discomfort at the injection site is possible. Rotating injection sites reduces this. Most patients experience no significant injection site issues.
Starting at 0.25mg and advancing only every 4 weeks gives your body maximum time to adapt. This protocol dramatically reduces side effect severity versus aggressive dosing.
Smaller, more frequent meals and reducing high-fat foods significantly reduces nausea. Our team provides specific practical guidance for the first weeks of treatment
Adequate hydration supports gastrointestinal comfort throughout treatment. We provide a practical hydration strategy alongside your medication instructions.
Side effects that become difficult to manage should be reported promptly. We can pause titration, adjust your dose timing, or recommend additional supportive care.
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone your gut naturally produces after eating to signal fullness. It suppresses appetite by acting on hunger centers in the brain, slows gastric emptying to keep you feeling fuller longer, and improves blood sugar control by stimulating insulin release. The STEP-1 trial demonstrated an average 14.9% body weight reduction over 68 weeks. It is available under the brand names Ozempic® and Wegovy®.
The STEP-1 Phase 3 clinical trial showed an average body weight reduction of 14.9% over 68 weeks with Semaglutide 2.4mg. 86% of patients achieved at least 5% weight loss, and 69% achieved at least 10%. Individual results depend on adherence to your provider’s complete program — including medication, nutritional guidance, and follow-up check-ins. Results are not guaranteed and vary by individual.
Yes. Restore Wellness Clinic offers NP-led telehealth semaglutide treatment for eligible patients in states where our provider is licensed.
Both Ozempic® and Wegovy® contain Semaglutide — the same active ingredient. Ozempic (0.5mg–2mg) is FDA-approved for the treatment of type 2 diabetes and is sometimes prescribed off-label for weight loss. Wegovy (2.4mg) is FDA-approved specifically for chronic weight management in adults with obesity or overweight. The higher dose in Wegovy is what was used in the STEP clinical trials producing 14.9% average weight loss. Your provider will determine the appropriate formulation and dose for your needs.
This is best determined during your consultation with our provider. Tirzepatide produces greater average weight loss (up to 22.5% vs. 14.9%) due to its dual GIP/GLP-1 mechanism. Semaglutide has a longer safety track record, extensive cardiovascular outcome data (20% CV risk reduction in SELECT trial), and a deeper evidence base in type 2 diabetes management. Some patients prioritize maximum weight loss results; others prioritize the most thoroughly studied long-term safety profile. Your provider will recommend the best option based on your health history, goals, and individual needs.
Semaglutide is administered as a once-weekly subcutaneous injection. It can be injected into the abdomen, thigh, or upper arm. Our team provides thorough injection training at your first appointment the technique is simple and most patients become comfortable within the first few doses.
The most common side effects are gastrointestinal nausea, mild stomach discomfort, and reduced appetite. These are most common during the early weeks and at each dose escalation step. The gradual titration protocol (starting at 0.25mg) significantly reduces their severity. Most patients find that side effects diminish substantially within 4–8 weeks as their body adapts. Dietary modifications and our team’s guidance help most patients move through the adjustment period comfortably.
Getting started is easy. Schedule your virtual consultation through our secure Tebra patient portal or call our office to book an appointment.
Serving patients in:
Semaglutide is not a trend – it’s one of the most studied and trusted weight loss medications ever developed. With provider supervision, a personalized dosing protocol, and the strongest long-term safety data available, Restore Wellness Clinic is ready to help you achieve results that last.
